Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
00241 ALI HEALTH
6.110-0.230-3.63%
Market Close
02/08 16:08 CCT
High
6.340
Open
6.340
Turnover
634.02M
Low
5.960
Pre Close
6.340
Volume
104.13M
Price Forecast
News
Comment
Ali Health: 2022 Interim Report
Alibaba Health Information Technology: six months ended September 30th, 2022 Interim results announcement
Recent Gains in Alibaba Health Information Technology Limited (HKG:241) Help Add Back Some Value on Insider Purchases Worth CN¥8.7m, Still Down CN¥2.1m
Insiders who purchased CN¥8.7m worth of Alibaba Health Information Technology Limited (HKG:241) shares over the past year recouped some of their losses after price gained 13% last week. However, tota
South China Financial Offloads More Shares in Alibaba Health
08:15 AM EST, 11/16/2022 (MT Newswires) -- South China Financial Holdings (HKG:0619) sold its 458,000 shares in Alibaba Health Information Technology (HKG:0241) in the secondary market for HK$2.7 mill
Pfizer Inc China cooperates with Alibaba Health Information Technology to carry out disease education
In order to better raise public awareness of disease, at the Fifth China International Import Expo, Pfizer Inc China and Alibaba Health Information Technology signed a strategic agreement on innovative cooperation in disease education, and the two sides worked together to carry out disease education to help realize "healthy China 2030". (PR Newswire headline)
Alibaba Health Information Technology: positive profit forecast
Alibaba Health Information Technology Limited's (HKG:241) Last Week's 7.8% Decline Must Have Disappointed Public Companies Who Have a Significant Stake
If you want to know who really controls Alibaba Health Information Technology Limited (HKG:241), then you'll have to look at the makeup of its share registry. The group holding the most number of sha
Alibaba Health Information Technology (HKG:241) Shareholders Have Endured a 67% Loss From Investing in the Stock a Year Ago
The nature of investing is that you win some, and you lose some. Unfortunately, shareholders of Alibaba Health Information Technology Limited (HKG:241) have suffered share price declines over the las
Alibaba Health Outlook Brightens on Rollout of China's Drug Sales Regulation -- Market Talk
0450 GMT - The long-awaited rollout of China's online drug sales regulation brightens Alibaba Health's outlook, Daiwa analyst Leon Qi says in a note. The regulation "sets up a formal legal framework i
Alibaba Health Information Technology Ltd. Raised to Outperform From Hold by Daiwa Capital Markets
Alibaba Health Information Technology Ltd. Raised to Outperform From Hold by Daiwa Capital Markets
Company Overview
More
The company is an investment holding company, and the Group is committed to providing Internet technology and service tools and platforms to partners in the industry to achieve the goal of providing inclusive and accessible medical and health services to the public and making health accessible to the public. The Group's main business includes proprietary pharmaceutical business, operation of pharmaceutical e-commerce platforms, consumer medical service platforms, provision of traceability and digital medical services, and Internet medical services.
CEO： Shunyan Zhu
Market： Hong Kong motherboard
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet